Pancreatic Cancer Recurrence after Whipple

Posted by joannc63 @joannc63, Feb 18, 2023

Hello. I had the Whipple surgery on 6/30/2020 for stage 3 Pancreatic cancer. I found out on 2/17/23 via CT scans that it is back in the pancreatitis bed and a noldule in my liver. I see my oncologist in 2 days to go over starting chemo again. I have back pain and abdominal pain from the recurrence. Has anyone had luck with chemo when the cancer returns? I hope the oncologist can get the tumor to shrink. I guess I am just looking for hope maybe this can get under control. Thank you.

Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.

@lhomrich

Your story is amazing. My husband had the whipple in February 2024 and in June of this year he was told his cancer was back. It is in the pancreatic bed and spread to the liver. They have started him on the appropriate chemo treatment. I now wish they would have continued with chemo treatments after his surgery. Hoping we have some positive outcome.

Jump to this post

Hello @lhomrich and welcome to the Pancreatic Cancer Support Group on Mayo Connect. As the other members have said, I'm sorry to learn of your husband's recurrence. That is disheartening to say the least.

A second opinion at a Pancreatic Center of Excellence might be helpful. Mayo Clinic has a lot of great oncologists who deal with pancreatic cancer. If you would like to consult with a Mayo oncologist, either in-person or virtually, at any of Mayo's three locations, here is a link with appointment information, http://mayocl.in/1mtmR63.

If an appointment with Mayo is not possible for any reason, here is a link to the National Pancreatic Cancer Foundation, https://www.npcf.us/. This organization might be able to put you in touch with another Pancreatic Cancer Center of Excellence.

How is your husband feeling since his surgery in February? Has his appetite or weight changed much?

REPLY

My guess is the first Whipple procedure Doctor missed limp nodes, or something that should have been removed. So sorry to hear this a referal might be a good thing. GodsSpeed..,

REPLY
@lhomrich

Your story is amazing. My husband had the whipple in February 2024 and in June of this year he was told his cancer was back. It is in the pancreatic bed and spread to the liver. They have started him on the appropriate chemo treatment. I now wish they would have continued with chemo treatments after his surgery. Hoping we have some positive outcome.

Jump to this post

I’m so sorry to hear this. I heard that they can’t start chemo right away because he needs to be strong enough to handle it. I’m sure it doesn’t help but it’s a little.

REPLY
@stageivsurvivor

My story is a little different but worth telling here. I had a Whipple procedure in 2012 and was staged as III, locally advanced, borderline resectable. Surgical margins were clear. There was portal vein resection required and pathology showed invasion into the vascular wall. Eleven of 22 lymph nodes were positive. One week after surgery a CT was done and the radiologist noted suspicion of metastatic disease to the liver. It was not large enough to be seen two weeks earlier at the time of the initial CT scan. So this was how I ended up having a Whipple and being stage IV…..it had not been detected prior to surgery that was done a couple of days after the initial diagnosis. No cure was to be achieved for me by having the Whipple.

My first thoughts on treatment were to find a clinical trial. To make the search easier, molecular profiling was done and a liquid biopsy revealed a germline (inherited) mutation. So now I knew the type of trials to focus my search on. A trial matching my criteria would take 14 months so in the meantime, standard of care chemo was required. Standard of care is just what it means….and it was not going to give me the longevity in survival I was looking for. I knew I would require better than SoC and strongly advocated for more aggressive chemo.

The “gold standard” of chemotherapy regimens in 2012 as it is today is Folfirinox. Administering 12 cycles is the number selected that is felt to achieve No Evidence of Disease (NED) and yet be tolerable by the majority of patients as adverse events, side effects and peripheral neuropathy are concerns. Few oncologists explain what NED means, especially in how it is determined. The goal of the oncologist is to knock the disease down low enough that it is not detectable by current sensitivity by imaging such as CT, MRI or PET. It is hoped that at this level, one’s immune system can keep any minimal residual disease (MRD) in check. As long as one continues to have a robust immune status, the MRD is held in check. But is the immune system comes under challenge and gets compromised, MRD can come back and usually in a more aggressive form.

Knowing this is why I advocated for more aggressive treatment with Folfirinox. Rather than stopping at 12 cycles, I indicated my desire and committed to doing as much as my body would tolerate. Thankfully my oncologist honored my request. Because neuropathy would likely be experienced and could become permanent, he decided to treat with six cycles of Folfirinox (FFX) followed by six resting cycles of just 5-FU with Leucovorin. After those six cycles, it was back to full-dose FFX for another six cycles. This alternating dosing regimen went for 24 months resulting in a total of 46 cycles of 24 FFX and 22 of 5-FU. At that point, a clinical trial opened that I met the criteria for and enrolled after a two week washout period. After the final 5-FU treatment, all liver metastasis had shrunk 80% and it was believed only scar tissue was being observed on imaging.

The clinical trial was designed to target a gene mutation for maintenance monotherapy. Many oncologists feel it was the excessive FFX that destroyed any MRD and the clinical trial drug has helped in preventing any new primary tumor from forming in the residual pancreas as I have a lifetime risk from that gene mutation.

Anyone can say to their oncologist they want to survive and be cured. Saying and doing are two very different things. I was 55 years old and strong physically from having done 100-200 mile bike rides per week. I was also strong emotionally and mentally. I set realistic expectations that setbacks might be encountered. I found ways to tolerate the treatment, deal with a setback and then move forward. I stayed focused on my goal and had the determination and very strong will to survive. In 2016 at the conclusion of the trial I was declared NED. It was likely I was already NED at the conclusion of the FFX treatments. In 2022 I was informed by a number of pancreatic cancer oncologists that they consider me cured. In a few months I will be celebrating 11 years of survival of having had stage IV disease.

Jump to this post

Your story is amazing. My husband had the whipple in February 2024 and in June of this year he was told his cancer was back. It is in the pancreatic bed and spread to the liver. They have started him on the appropriate chemo treatment. I now wish they would have continued with chemo treatments after his surgery. Hoping we have some positive outcome.

REPLY
@pete1962

Hi

I finally got my first result since I am on Landerotide. The comparison was between a CT scan that I had in Dec 2022 vs. one in June 2023. I have been on Landerotide since March.

It appears that my tumors have shrunk a little bit which is obviously great news. I did not expect this result since according to my specialist it is very common that the first scan after treatment starts might even show a growth of the cells. I will have my next result probably early December and hopefully the progress continuous....fingers crossed.

Keep your spirit up, there is a lot of possibilities out there to treat NET and NELM.

Jump to this post

Hello @pete1962

I'm so pleased, as I am sure you are, for your good results! I appreciate you posting this encouraging news. It certainly helps all of us with NETs to know that there are treatments that help.

I look forward to hearing from you again!

REPLY

Hi

I finally got my first result since I am on Landerotide. The comparison was between a CT scan that I had in Dec 2022 vs. one in June 2023. I have been on Landerotide since March.

It appears that my tumors have shrunk a little bit which is obviously great news. I did not expect this result since according to my specialist it is very common that the first scan after treatment starts might even show a growth of the cells. I will have my next result probably early December and hopefully the progress continuous....fingers crossed.

Keep your spirit up, there is a lot of possibilities out there to treat NET and NELM.

REPLY
@pete1962

SSA = somatostatin analogues
In the UK the MDT (multidisciplinary teams) have a max of 6 weeks to review CT scans. There are two main issues: a CT scan is not as clear as a PET scan but less stress on the body. This makes it more difficult to assess any progress. The second issue is that this last scan is more seen as a benchmark scan and regression of the Tumor is apparently not expected. Will get the results coming Wednesday, fingers crossed.

Jump to this post

@pete1962,

I hope that the results that you get on Wednesday will provide you with good results and a treatment plan going forward.

Will you post an update as it's convenient for you?

REPLY
@gamaryanne

Peter, what is an SSA injection?
I am surprised a CT scan in June would not return results in over a month. I hope it’s back by now and the results are positive!

Jump to this post

Hi @gamaryanne

I see that @stageivsurvivor has given you some information on SSA injections.

Here is a link to specific information. As you can see, it is used to treat neuroendocrine tumors (NETs).
https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment/somatostatin-analogues/what-are

REPLY
@gamaryanne

Peter, what is an SSA injection?
I am surprised a CT scan in June would not return results in over a month. I hope it’s back by now and the results are positive!

Jump to this post

SSA= Somatostatin Analog used for treating Neuroendocrine tumors.

REPLY

SSA = somatostatin analogues
In the UK the MDT (multidisciplinary teams) have a max of 6 weeks to review CT scans. There are two main issues: a CT scan is not as clear as a PET scan but less stress on the body. This makes it more difficult to assess any progress. The second issue is that this last scan is more seen as a benchmark scan and regression of the Tumor is apparently not expected. Will get the results coming Wednesday, fingers crossed.

REPLY
Please sign in or register to post a reply.